Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (16)

2024

  1. Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

2023

  1. Exploring the Metabolic Differences between Cisplatin- and UV Light-Induced Apoptotic Bodies in HK-2 Cells by an Untargeted Metabolomics Approach

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Prostaglandin transporter PGT as a new pharmacological target in the prevention of inflammatory cytokine-induced injury in renal proximal tubular HK-2 cells

    Life Sciences, Vol. 313

2021

  1. Intracellular prostaglandin E2 contributes to hypoxia-induced proximal tubular cell death

    Scientific Reports, Vol. 11, Núm. 1

  2. Mitochondria selective trackers for long-term imaging based on readily accessible neutral BODIPYs

    Chemical Communications, Vol. 57, Núm. 43, pp. 5318-5321

2020

  1. Author Correction: Mechanism and Consequences of The Impaired Hif-1α Response to Hypoxia in Human Proximal Tubular HK-2 Cells Exposed to High Glucose (Scientific Reports, (2019), 9, 1, (15868), 10.1038/s41598-019-52310-6)

    Scientific Reports

  2. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 7

2019

  1. PROSTAGLANDIN E 2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2

    Journal of Cellular Physiology, Vol. 234, Núm. 5, pp. 7548-7559

  2. Apoptosis and cell proliferation in proximal tubular cells exposed to apoptotic bodies. Novel pathophysiological implications in cisplatin-induced renal injury

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1865, Núm. 9, pp. 2504-2515

  3. Mechanism and Consequences of The Impaired Hif-1α Response to Hypoxia in Human Proximal Tubular HK-2 Cells Exposed to High Glucose

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways

    Journal of Cellular Physiology, Vol. 233, Núm. 4, pp. 3590-3602

2017

  1. Aligned copper nanowires as a cut-and-paste exclusive electrochemical transducer for free-enzyme highly selective quantification of intracellular hydrogen peroxide in cisplatin-treated cells

    Biosensors and Bioelectronics, Vol. 96, pp. 146-151

2016

  1. Intracellular prostaglandin E2 mediates cisplatin-induced proximal tubular cell death

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1863, Núm. 2, pp. 293-302

2009

  1. 15-Deoxy-Δ12,14-prostaglandin-J2 reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1α degradation

    Cellular and Molecular Life Sciences, Vol. 66, Núm. 13, pp. 2167-2180

2007

  1. Accumulation of hypoxia-inducible factor-1α through a novel electrophilic, thiol antioxidant-sensitive mechanism

    Cellular Signalling, Vol. 19, Núm. 10, pp. 2098-2105

  2. Therapeutic effect of all-trans-retinoic acid (at-RA) on an autoimmune nephritis experimental model: Role of the VLA-4 integrin

    BMC Nephrology, Vol. 8